iBio Inc (IBIO)
1.72
-0.18
(-9.47%)
USD |
NYAM |
Apr 25, 16:00
1.69
-0.03
(-1.74%)
Pre-Market: 20:00
iBio Shareholders Equity (Quarterly): 9.197M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 9.197M |
September 30, 2023 | 13.21M |
June 30, 2023 | 15.38M |
March 31, 2023 | 17.39M |
December 31, 2022 | 18.82M |
September 30, 2022 | 48.37M |
June 30, 2022 | 63.48M |
March 31, 2022 | 79.38M |
December 31, 2021 | 90.60M |
September 30, 2021 | 100.54M |
June 30, 2021 | 108.58M |
March 31, 2021 | 104.84M |
December 31, 2020 | 107.34M |
September 30, 2020 | 80.05M |
June 30, 2020 | 56.62M |
March 31, 2020 | 3.966M |
December 31, 2019 | -0.511M |
September 30, 2019 | -1.933M |
June 30, 2019 | 2.463M |
March 31, 2019 | 6.907M |
December 31, 2018 | 11.08M |
September 30, 2018 | 13.03M |
June 30, 2018 | 16.17M |
March 31, 2018 | 4.154M |
December 31, 2017 | 7.812M |
Date | Value |
---|---|
September 30, 2017 | 6.293M |
June 30, 2017 | 8.914M |
March 31, 2017 | 12.95M |
December 31, 2016 | 4.153M |
September 30, 2016 | 7.141M |
June 30, 2016 | 9.937M |
March 31, 2016 | 8.265M |
December 31, 2015 | 7.878M |
September 30, 2015 | 9.809M |
June 30, 2015 | 11.23M |
March 31, 2015 | 10.19M |
December 31, 2014 | 9.567M |
September 30, 2014 | 5.439M |
June 30, 2014 | 6.099M |
March 31, 2014 | 7.001M |
December 31, 2013 | 7.954M |
September 30, 2013 | 5.682M |
June 30, 2013 | 5.068M |
March 31, 2013 | 2.298M |
December 31, 2012 | 3.717M |
September 30, 2012 | 4.571M |
June 30, 2012 | 6.169M |
March 31, 2012 | 6.854M |
December 31, 2011 | 0.3055M |
September 30, 2011 | 0.8861M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-1.933M
Minimum
Sep 2019
108.58M
Maximum
Jun 2021
48.30M
Average
48.37M
Median
Sep 2022
Shareholders Equity (Quarterly) Benchmarks
Lixte Biotechnology Holdings Inc | 3.995M |
PAVmed Inc | -53.83M |
Avalo Therapeutics Inc | 7.304M |
Imunon Inc | 13.39M |
Ocugen Inc | 40.56M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 34.02M |
Total Liabilities (Quarterly) | 24.82M |